| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 03/21/2002 | WO2002022621A2 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS |
| 03/21/2002 | WO2002022620A2 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin f2$g(a) antagonists |
| 03/21/2002 | WO2002022619A1 Process for preparation of 7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylic acid derivatives |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022602A2 Triazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022600A2 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | WO2002022594A1 H-annellated benzo[f]chromenes |
| 03/21/2002 | US20020033479 Light-reaction type optically active compound, light-reaction type chiral agent, liquid crystal composition, liquid crystal color filter, optical film, recording medium, and method of changing twist structure of liquid crystal |
| 03/21/2002 | CA2432780A1 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin f25g(a) antagonists |
| 03/21/2002 | CA2422233A1 Interphenylene 7-oxabicyclic[2.2.1]heptane oxazoles as prostaglandin f2aantagonists |
| 03/21/2002 | CA2419224A1 Chemokine receptor binding heterocyclic compounds |
| 03/20/2002 | EP1187604A1 Compounds and methods for the treatment of post traumatic stress disorder |
| 03/20/2002 | EP1165627A4 Photopolymerizable vinyl ether based monomeric formulations and polymerizable compositions which may include certain novel spiroorthocarbonates |
| 03/20/2002 | CN1341115A 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use |
| 03/20/2002 | CN1341114A C-21 Modified epothilones |
| 03/19/2002 | US6359151 Use as pesticides. |
| 03/19/2002 | US6359140 Hydrogenation, halogenation, epoxidation, reduction of epoxide to alcohol |
| 03/19/2002 | US6358998 Body fat-reducing agent comprising dioxabicyclo[3.3.0] octane derivative as active ingredient |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/14/2002 | WO2002020528A2 Fluorinated and alkylated alditol derivatives and polyolefin articles containing same |
| 03/14/2002 | WO2002020514A1 Multivalent neuraminidase inhibitor conjugates |
| 03/14/2002 | WO2002020509A2 Medicaments against viral infections |
| 03/14/2002 | WO2002020447A1 Method of producing fluorinated and chlorinated benzaldehydes and compositions thereof |
| 03/14/2002 | WO2001059126A3 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 03/14/2002 | US20020032362 Method of manufacturing a soft hearing aid |
| 03/14/2002 | US20020032352 Reacting a cyclohexanedione or chromene-one derivative with 1,8-diazabicyclo(5.4.0)undec-7ene |
| 03/14/2002 | US20020032308 Oocydin and methods of use for protection of plants from Oomyocyte pathogens |
| 03/14/2002 | US20020032161 Cyclodextrin compositions |
| 03/14/2002 | DE10043791A1 Antiviral medicaments containing new or known chroman-4-one or chroman-4-one derivatives, especially effective against hepatitis B virus infections |
| 03/14/2002 | CA2416336A1 Multivalent neuraminidase inhibitor conjugates |
| 03/13/2002 | EP1186606A1 Epothilone derivatives, their preparation and utilization |
| 03/13/2002 | EP1185534A1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP0805155B1 Novel antioxidant tricyclic fused heterocyclic compound |
| 03/13/2002 | CN1340053A Epothilon derivatives, method for the production and the use as pharmaceuticals |
| 03/13/2002 | CN1080722C Hexagonal diacdetal crystal and resin nucleating agent containing the crystal |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/12/2002 | US6355660 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/12/2002 | US6355441 Benzothiazole dioxetanes |
| 03/12/2002 | US6354990 Soft hearing aid |
| 03/12/2002 | CA2055947C Condensed heterocyclic compounds, their production and use |
| 03/07/2002 | WO2002018391A1 Compounds containing oxazolidinone moiety and uses thereof |
| 03/07/2002 | WO2002018362A1 Reagent for determining singlet oxygen |
| 03/07/2002 | US20020028959 Process for the manufacture of anhydro sugar alcohols with the assistance of a gas purge |
| 03/07/2002 | US20020028955 Chirality conversion method in lactone sugar compounds |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028864 Preparing a slurry of diacetal in a solvent and swelling the diacetal, uniformaly mixing the slurry with a binder (carboxylic, organic sulfonic, sulfuric, phosphoric or metal acid eter), removing the solvent, or granulating or sifting |
| 03/07/2002 | US20020028839 Cancer treatment with epothilones |
| 03/07/2002 | US20020028748 Chemical intermediates |
| 03/07/2002 | CA2421309A1 Compounds containing oxazolidinone moiety and uses thereof |
| 03/06/2002 | EP1184379A1 Chromene compound |
| 03/06/2002 | EP0876372B1 Heteroarylcarboxamide derivatives |
| 03/06/2002 | CN1338457A 3 alpha-bromoepipodophyllotoxin, its position-4 substituted derivative and preparing process thereof |
| 03/06/2002 | CN1080283C Synergic stabilizato mixture |
| 03/05/2002 | US6353119 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 03/05/2002 | US6353105 Inhibitors of 5-hydroxy-tryptamine reuptake of a monoamine transporter; analogs of cocaine; |
| 03/05/2002 | US6353002 Therapeutic agents |
| 02/28/2002 | WO2002016369A2 Novel macrocycles and uses thereof |
| 02/28/2002 | WO2002009734A8 Sugar absorption inhibitors and process for producing the same |
| 02/28/2002 | WO2001092255A3 Epothilone derivatives and methods for making and using the same |
| 02/28/2002 | WO2001074741A3 Catalytic asymmetric desymmetrization of meso compounds |
| 02/28/2002 | US20020025946 Acylated cyclodextrin: guest molecule inclusion complexes |
| 02/28/2002 | DE10041470A1 New 6-substituted 12,13-(cyclopropyl or azacyclopropyl)-epothilone derivatives, useful as cell division regulators for treating e.g. malignant tumors, psoriasis or arthritis |
| 02/27/2002 | EP1180991A2 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
| 02/27/2002 | EP0946536B1 (benzofuran)naphthopyrans, the compositions and (co)polymer matrices containing them |
| 02/27/2002 | EP0828506B1 Endoparasiticidal agents |
| 02/27/2002 | EP0643626B1 Method of producing epoxychromans with a chiral catalyst |
| 02/27/2002 | CN1079798C 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as antiparasitic agents, and the intermediate |
| 02/26/2002 | CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/21/2002 | WO2002014529A1 Curvularol and process for preparation of the same |
| 02/21/2002 | WO2001078162A3 Oligomeric and polymeric oled materials produced via arylation of quinones |
| 02/21/2002 | US20020022729 Pyridylfuran and pyridylthiophene compounds |
| 02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
| 02/21/2002 | DE10039477A1 Heterocyclylalkylazol-Derivate und ihre Verwendung als Schädlingsbekämpfungsmittel Heterocyclylalkylazol derivatives and their use as pesticides |
| 02/20/2002 | EP1180109A1 Prodrug activation using catalytic antibodies |
| 02/20/2002 | EP1180106A1 4-substituted milbemycin derivatives |
| 02/20/2002 | EP0915865B1 Covalently immobilised fluoroionophores for optical ion sensors |
| 02/19/2002 | US6348608 Catalytic asymmetric epoxidation |
| 02/19/2002 | US6348604 Photochromic naphthopyrans |
| 02/14/2002 | WO2002012223A2 Synthetic salicylihalamides, apicularens and derivatives thereof |
| 02/14/2002 | WO2002012215A1 Process for the preparation of baccatin iii derivatives |
| 02/14/2002 | WO2002011677A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 02/14/2002 | US20020019544 Bioavailability |
| 02/14/2002 | US20020019439 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity |
| 02/14/2002 | CA2418083A1 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 02/14/2002 | CA2417994A1 Synthetic salicylihalamides, apicularens and derivatives thereof |
| 02/13/2002 | CN1335157A Systemic separation process and prepn of ginkgetin, ginkgolide and bilobalide |
| 02/12/2002 | US6346631 Process for the preparation of arteethers from dihydroartemisinin |
| 02/12/2002 | CA2214871C Process for preparing spirolaxine and spirolaxine methyl ether |
| 02/12/2002 | CA2057504C Process for preparing new n-acyl-2,3-benzodiazepine derivatives, their acid addition salts and pharmaceutical compositions containing the same |
| 02/07/2002 | WO2002010230A1 Polymerization of olefinic orthoesters |
| 02/07/2002 | WO2002009756A1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient |
| 02/07/2002 | WO2002009734A1 Sugar absorption inhibitors and process for producing the same |
| 02/07/2002 | WO2002009696A1 Methods for treating cell proliferative disorders and viral infections |